Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1978 Jul;21(1):275–280. doi: 10.1128/iai.21.1.275-280.1978

Interstitial pneumonia and subclinical infection after intranasal inoculation of murine cytomegalovirus.

M C Jordan
PMCID: PMC421986  PMID: 213384

Abstract

Although cytomegalovirus (CMV) infections are common throughout the world, little is known about the means of person-to-person transmission. To determine whether infection could be established by a respiratory route, studies were conducted in a murine CMV (MCMV) model by using intranasal inoculation. The infectious dose which resulted in pulmonary and systemic infection of half the mice was 100 plaque-forming units of MCMV. Here, infection was subclinical, but virus replicated in the lungs and subsequently disseminated via the blood to other organs within 7 days. The serum immunofluorescence antibody titer peaked by day 21. None of these mice died, although focal peribronchial interstitial pneumonitis was found in infected animals. In mice given greater than or equal to 10(4) plaque-forming units of MCMV intranasally, severe diffuse interstitial pneumonitis resulted uniformly, closely resembling that seen in immunocompromised patients and in newborn infants, and 20% of the animals died. Normal pulmonary architecture was obliterated by sheets of histiocytes, many containing MCMV intranuclear inclusions, and by accumulation of proteinaceous fluid in the interstitial and alveolar spaces. Of relevance to human disease, these experiments show that MCMV as a sole pathogen can cause severe interstitial pneumonitis in normal mice and that subclinical systemic infection results from respiratory inoculation of small amounts of virus.

Full text

PDF
279

Images in this article

277Image
on p.277
278Image
on p.278
278Image
on p.278
279Image
on p.279

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdallah P. S., Mark J. B., Merigan T. C. Diagnosis of cytomegalovirus pneumonia in compromised hosts. Am J Med. 1976 Sep;61(3):326–332. doi: 10.1016/0002-9343(76)90368-5. [DOI] [PubMed] [Google Scholar]
  2. Brody A. R., Craighead J. E. Pathogenesis of pulmonary cytomegalovirus infection in immunosuppressed mice. J Infect Dis. 1974 Jun;129(6):677–689. doi: 10.1093/infdis/129.6.677. [DOI] [PubMed] [Google Scholar]
  3. Craighead J. E. Cytomegalovirus pulmonary disease. Pathobiol Annu. 1975;5:197–220. [PubMed] [Google Scholar]
  4. Craighead J. E. Pulmonary cytomegalovirus infection in the adult. Am J Pathol. 1971 Jun;63(3):487–504. [PMC free article] [PubMed] [Google Scholar]
  5. Hanshaw J. B. Cytomegalovirus complement-fixing antibody in microcephaly. N Engl J Med. 1966 Sep 1;275(9):476–479. doi: 10.1056/NEJM196609012750905. [DOI] [PubMed] [Google Scholar]
  6. Henson D., Smith R. D., Gehrke J. Non-fatal mouse cytomegalovirus hepatitis. Combined morphologic, virologic and immunologic observations. Am J Pathol. 1966 Nov;49(5):871–888. [PMC free article] [PubMed] [Google Scholar]
  7. Jordan M. C., Shanley J. D., Stevens J. G. Immunosuppression reactivates and disseminates latent murine cytomegalovirus. J Gen Virol. 1977 Nov;37(2):419–423. doi: 10.1099/0022-1317-37-2-419. [DOI] [PubMed] [Google Scholar]
  8. MANNINI A., MEDEARIS D. N., Jr Mouse salivary gland virus infections. Am J Hyg. 1961 May;73:329–343. doi: 10.1093/oxfordjournals.aje.a120192. [DOI] [PubMed] [Google Scholar]
  9. MEDEARIS D. N., Jr MOUSE CYTOMEGALOVIRUS INFECTION. II. OBSERVATIONS DURING PROLONGED INFECTIONS. Am J Hyg. 1964 Jul;80:103–112. [PubMed] [Google Scholar]
  10. Mayo D. R., Armstrong J. A., Ho M. Reactivation of murine cytomegalovirus by cyclophosphamide. Nature. 1977 Jun 23;267(5613):721–723. doi: 10.1038/267721a0. [DOI] [PubMed] [Google Scholar]
  11. Myers J. D., Spencer H. C., Jr, Watts J. C., Gregg M. B., Stewart J. A., Troupin R. H., Thomas E. D. Cytomegalovirus pneumonia after human marrow transplantation. Ann Intern Med. 1975 Feb;82(2):181–188. doi: 10.7326/0003-4819-82-2-181. [DOI] [PubMed] [Google Scholar]
  12. Numazaki Y., Yano N., Morizuka T., Takai S., Ishida N. Primary infection with human cytomegalovirus: virus isolation from healthy infants and pregnant women. Am J Epidemiol. 1970 Apr;91(4):410–417. doi: 10.1093/oxfordjournals.aje.a121151. [DOI] [PubMed] [Google Scholar]
  13. Olding L. B., Jensen F. C., Oldstone M. B. Pathogenesis of of cytomegalovirus infection. I. Activation of virus from bone marrow-derived lymphocytes by in vitro allogenic reaction. J Exp Med. 1975 Mar 1;141(3):561–572. doi: 10.1084/jem.141.3.561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. ROWE W. P., HARTLEY J. W., CRAMBLETT H. G., MASTROTA F. M. Detection of human salivary gland virus in the mouth and urine of children. Am J Hyg. 1958 Jan;67(1):57–65. doi: 10.1093/oxfordjournals.aje.a119919. [DOI] [PubMed] [Google Scholar]
  15. STERN H., ELEK S. D. THE INCIDENCE OF INFECTION WITH CYTOMEGALOVIRUS IN A NORMAL POPULATION. A SEROLOGICAL STUDY IN GREATER LONDON. J Hyg (Lond) 1965 Mar;63:79–87. doi: 10.1017/s0022172400044983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Selgrade M. K., Osborn J. E. Role of macrophages in resistance to murine cytomegalovirus. Infect Immun. 1974 Dec;10(6):1383–1390. doi: 10.1128/iai.10.6.1383-1390.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Weller T. H. The cytomegaloviruses: ubiquitous agents with protean clinical manifestations. II. N Engl J Med. 1971 Jul 29;285(5):267–274. doi: 10.1056/NEJM197107292850507. [DOI] [PubMed] [Google Scholar]
  18. Whitley R. J., Brasfield D., Reynolds D. W., Stagno S., Tiller R. E., Alford C. A. Protracted pneumonitis in young infants associated with perinatally acquired cytomegaloviral infection. J Pediatr. 1976 Jul;89(1):16–22. doi: 10.1016/s0022-3476(76)80919-5. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES